Latest Updates

Supercharging flu vaccine for vulnerable Australians

Clinical trial to test benefits of fibre supplement to enhance flu vaccine.

Read more

Vaccine patch trial success

Vaxxas’ micro-needle patch demonstrated significantly enhanced immune response compared to vaccination by needle/syringe.

READ MORE

Source of inflammation found for Rheumatoid arthritis

Researchers find new details about how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack.

READ MORE

An Australian-first initiative of 'bench to bedside' medical research

The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.

The work conducted at TRI is translational research, a research process which involves teams of patients, clinicians and researchers working together to solve health challenges faster. The work is driven by the needs of patients, a question formed by a clinician and a solution sought by a scientist.

Find out more

What is Translational Research?

Also known as 'bench-to-bedside' research, it is a type of medical research that focusses on 'translating' basic science discoveries from the laboratory into the clinic.

The aim is to improve how we detect, diagnose and treat health conditions, and improve health outcomes for patients.

At TRI, we work to develop new treatments and diagnostics for conditions ranging from various cancers to autoimmune diseases, and translate these discoveries into improved healthcare.

Find out more

What's On

No upcoming events.